Ascend FDA Monday, October 22, 2018 0.00 Neutral

FDA Approves METFORMIN HYDROCHLORIDE — Ascend Laboratories, LLC

FDA approved the ANDA for Metformin Hydrochloride manufactured by Ascend Laboratories, LLC, granting the firm market authorization for the generic version of the widely used type 2 diabetes medication. This diversification of supply chains could improve commercial viability for the manufacturer, though the approval faces a limited commercial window given the popular launch of branded generics by Mylan in 2016.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day